Skip to main content
. 2022 Jan;183:109152. doi: 10.1016/j.diabres.2021.109152

Fig. 1.

Fig. 1

Cost-effectiveness plane showing the distribution of lifetime incremental costs and quality-adjusted life-years (QALYs) in a US setting (A) and in a UK setting (B). Grey diagonal lines show the value indicating the commonly cited cost-effectiveness thresholds for society’s willingness to pay for a QALY gained (USD 100,000 [A] and GBP 20,000 [B], respectively).